KEB Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
KEB Asset Management's BMY Position: Q3 2026 in Review
KEB Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 600 shares — an estimated $34.6K sold.
KEB Asset Management first reported a position in BMY in Q4 2021 and held it in 10 quarters. The position peaked at $331K in Q2 2022. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- KEB Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- KEB Asset Management sold 600 Bristol-Myers Squibb shares in Q3 2026, an estimated $34.6K.
- KEB Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 10 quarters.
- KEB Asset Management's Bristol-Myers Squibb position peaked at $331K in Q2 2022.
- 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on KEB Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.